$128 Million is the total value of TRV GP III, LLC's 5 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVMD | Sell | REVOLUTION MEDICINES, INC. | $38,210,377 | -46.2% | 1,604,130 | -55.5% | 29.95% | -3.5% |
| PLRX | Sell | PLIANT THERAPEUTICS, INC. | $35,550,963 | -55.7% | 1,839,160 | -52.1% | 27.86% | -20.4% |
| VYGR | VOYAGER THERAPEUTICS, INC. | $33,116,491 | +3.0% | 5,428,933 | 0.0% | 25.95% | +84.9% | |
| FULC | Sell | FULCRUM THERAPEUTICS, INC. | $14,284,831 | -55.4% | 1,962,202 | -50.5% | 11.20% | -20.0% |
| DBTX | DECIBEL THERAPEUTICS, INC. | $6,436,354 | -40.7% | 3,139,685 | 0.0% | 5.04% | +6.3% | |
| JNCE | Exit | JOUNCE THERAPEUTICS, INC. | $0 | – | -1,148,780 | -100.0% | -1.17% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Robert I. Tepper #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VOYAGER THERAPEUTICS, INC. | 22 | Q1 2023 | 74.0% |
| JOUNCE THERAPEUTICS, INC. | 20 | Q3 2022 | 24.5% |
| PLIANT THERAPEUTICS, INC. | 14 | Q3 2023 | 100.0% |
| FULCRUM THERAPEUTICS, INC. | 14 | Q4 2022 | 43.8% |
| REVOLUTION MEDICINES, INC. | 12 | Q4 2022 | 53.8% |
| DECIBEL THERAPEUTICS, INC. | 10 | Q2 2023 | 66.3% |
| NEON THERAPEUTICS, INC. | 8 | Q1 2020 | 41.1% |
| NURIX THERAPEUTICS, INC. | 8 | Q2 2022 | 17.7% |
| RELAY THERAPEUTICS, INC. | 2 | Q4 2020 | 37.7% |
| MYOKARDIA, INC. | 2 | Q1 2018 | 22.1% |
View TRV GP III, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 4 | 2023-02-06 |
| 4 | 2023-02-01 |
| 4 | 2023-01-31 |
| 4 | 2023-01-26 |
| 4 | 2023-01-24 |
View TRV GP III, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.